// App-Quantinova.ai

: A UK cost comparison of amikacin therapy with bedaquiline, for drug resistant tuberculosis

Researchers

Presenter

  • Kavina Manalan

Principal Investigators

  • Nathan Green

  • Amber Arnold

  • Graham Cooke

  • Martin Dedicoat

  • Marc Lipman

  • Thomas Harrison

  • Onn Min Kon

Medical Centers

  • Imperial College, London, United Kingdom

  • St Georges University Hospital, London, UK

  • Heart of England NHS Foundation Trust, Birmingham, United Kingdom

  • Kings College London, London, United Kingdom

  • St George's, University of London, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Tuberculosis

Biomarkers

  • N/A

Drug/Treatment

  • Bedaquiline

  • Hydroxyzine

  • Amikacin

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A